[HTML][HTML] Current states and future views in photodynamic therapy
S Yano, S Hirohara, M Obata, Y Hagiya, S Ogura… - … of Photochemistry and …, 2011 - Elsevier
One of the long-standing goals of both researchers and oncologists is to establish a
framework for the complete cure of cancer with less toxic adverse effect and improved …
framework for the complete cure of cancer with less toxic adverse effect and improved …
Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids
S Grassin-Delyle, A Buenestado, E Naline… - Pharmacology & …, 2012 - Elsevier
Intranasal administration is a non-invasive route for drug delivery, which is widely used for
the local treatment of rhinitis or nasal polyposis. Since drugs can be absorbed into the …
the local treatment of rhinitis or nasal polyposis. Since drugs can be absorbed into the …
Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water
Background Municipal drinking water contaminated with perfluorinated alkyl acids had been
distributed to one-third of households in Ronneby, Sweden. The source was firefighting …
distributed to one-third of households in Ronneby, Sweden. The source was firefighting …
[HTML][HTML] Development of a microphysiological model of human kidney proximal tubule function
EJ Weber, A Chapron, BD Chapron, JL Voellinger… - Kidney international, 2016 - Elsevier
The kidney proximal tubule is the primary site in the nephron for excretion of waste products
through a combination of active uptake and secretory processes and is also a primary target …
through a combination of active uptake and secretory processes and is also a primary target …
Predicting clearance mechanism in drug discovery: extended clearance classification system (ECCS)
MV Varma, SJ Steyn, C Allerton, AF El-Kattan - Pharmaceutical research, 2015 - Springer
Early prediction of clearance mechanisms allows for the rapid progression of drug discovery
and development programs, and facilitates risk assessment of the pharmacokinetic …
and development programs, and facilitates risk assessment of the pharmacokinetic …
The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA,“ecstasy”)
AR Green, AO Mechan, JM Elliott, E O'Shea… - Pharmacological …, 2003 - ASPET
The amphetamine derivative (±)-3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) is
a popular recreational drug among young people, particularly those involved in the dance …
a popular recreational drug among young people, particularly those involved in the dance …
What drives customer satisfaction and word of mouth in mobile commerce services? A UTAUT2-based analytical approach
What drives customer satisfaction and word of mouth in mobile commerce services? A
UTAUT2-based analytical approach | Emerald Insight Books and journals Case studies Expert …
UTAUT2-based analytical approach | Emerald Insight Books and journals Case studies Expert …
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
SF Zhou - Xenobiotica, 2008 - Taylor & Francis
1. P-glycoprotein (P-gp/MDR1), one of the most clinically important transmembrane
transporters in humans, is encoded by the ABCB1/MDR1 gene. Recent insights into the …
transporters in humans, is encoded by the ABCB1/MDR1 gene. Recent insights into the …
Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach
GD Anderson - Clinical pharmacokinetics, 2005 - Springer
Observational studies have documented that women take a variety of medications during
pregnancy. It is well known that pregnancy can induce changes in the plasma …
pregnancy. It is well known that pregnancy can induce changes in the plasma …
Renal transporters in drug development
KM Morrissey, SL Stocker, MB Wittwer… - Annual review of …, 2013 - annualreviews.org
The kidney plays a vital role in the body's defense against potentially toxic xenobiotics and
metabolic waste products through elimination pathways. In particular, secretory transporters …
metabolic waste products through elimination pathways. In particular, secretory transporters …